Recon: Work stalls after FDA staff cuts; Indian medtechs react to US tariff plans

• Drug Development Is Slowing Down After Cuts at the FDA (WSJ, Bloomberg Law)
• HHS funding slashed by 30 percent in budget proposal (Politico, STAT)
• UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care (STAT)
• Supreme Court to hear challenge to ACA rule requiring free preventive care, cancer screenings (STAT)
• Exclusive: US consumer safety agency to stop collecting swaths of data after CDC cuts (Reuters)

• Industry Keen On ‘Stepwise’ PIPs, But Future Hinges On EU Pharma Legislation Reform (Pink Sheet)
• Leqembi Launch Set For Germany & Austria After Winning EU Approval At Last (Pink Sheet)
• Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory Access (MedTech Insight)
• Keeping Germany’s Medtech Industry Apprised, Advised and Incentivized in Turbulent Times (MedTech Insight)

• Daily pill from Eli Lilly helps patients control blood sugar, lose weight, Phase 3 study shows (STAT)
• AstraZeneca unit sued over alleged monopoly on blockbuster drug Soliris (Reuters)
• Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne (Endpoints)
• Bayer lobbies US states in battle to keep glyphosate on market, CEO says (Reuters)
• US CDC advisers recommend lowering the age for RSV shots to 50-59 years (Reuters)

• Big changes coming to federal health IT regulator? (STAT)
• RadNet leaders discuss rationale behind blockbuster $103M iCAD AI acquisition (Radiation Business)
• Medical device maker Belluscura expects 20% tariff on products sold in US (Reuters)
• A judge blocked the FDA’s plan to regulate LDTs. What now? (MedTech Dive)
• J&J’s electrophysiology sales dip amid slow Varipulse start (MedTech Dive)
• DaVita hit by ransomware attack (MedTech Dive)
• Notified Bodies Warn Of Hurdles In The Way Of Their AI Designations (MedTech Insight)
• Guidance Comments Highlight Outstanding Questions In AI Development (MedTech Insight)

• Baby food makers are failing California’s lead standards, Reuters review shows (Reuters)
• How food giants are embracing AI to forecast recipes, regulatory hurdles (Food Dive)
• PepsiCo, Kraft Heinz face off with shareholder activists on sustainable packaging (Food Dive)

• Arkansas adopts first-in-the-nation law forcing companies to choose between running a PBM or pharmacies (STAT)
• What it took for Walgreens to go private (Endpoints)
• Health insurer Elevance sees first-quarter profit above estimates (Reuters)
• Trump's Plan to Lower Drug Prices Takes Aim at IRA 'Pill Penalty' (MedPage Today)